Gene · 5518
Papers1,733
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,733
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Unleashing the Power of Synthetic Lethality: Augmenting Treatment Efficacy through Synergistic Integration with Chemotherapy Drugs. | Pharmaceutics | 2023 | 37896193 | PubTator, text mining | PubMed |
| SET-PP2A complex as a new therapeutic target in KMT2A (MLL) rearranged AML. | Oncogene | 2023 | 37891368 | PubTator, text mining | PubMed |
| TERT promoter mutations and gene amplification in endometrial cancer. | Gynecol Oncol | 2023 | 37890416 | PubTator, text mining | PubMed |
| The tumor multi-omic landscape of endometrial cancers developed on a germline genetic background of adiposity. | medRxiv | 2023 | 37873386 | PubTator, text mining | PubMed |
| Interaction between huntingtin exon 1 and HEAT repeat structure probed by chimeric model proteins. | Protein Sci | 2023 | 37853955 | PubTator, text mining | PubMed |
| Identification of immune-related biomarkers in peripheral blood of schizophrenia using bioinformatic methods and machine learning algorithms. | Front Cell Neurosci | 2023 | 37841288 | PubTator, text mining | PubMed |
| Nicotine Exposure in a Phencyclidine-Induced Mice Model of Schizophrenia: Sex-Selective Medial Prefrontal Cortex Protein Markers of the Combined Insults in Adolescent Mice. | Int J Mol Sci | 2023 | 37834084 | PubTator, text mining | PubMed |
| Clinical Behavior and Molecular Landscape of Stage I p53-Abnormal Low-Grade Endometrioid Endometrial Carcinomas. | Clin Cancer Res | 2023 | 37773079 | PubTator, text mining | PubMed |
| Targeting DNA Damage Repair and Immune Checkpoint Proteins for Optimizing the Treatment of Endometrial Cancer. | Pharmaceutics | 2023 | 37765210 | PubTator, text mining | PubMed |
| Protein Phosphatase 2A as a Therapeutic Target in Pulmonary Diseases. | Medicina (Kaunas) | 2023 | 37763671 | PubTator, text mining | PubMed |
| Evaluating the Utility of ctDNA in Detecting Residual Cancer and Predicting Recurrence in Patients with Serous Ovarian Cancer. | Int J Mol Sci | 2023 | 37762691 | PubTator, text mining | PubMed |
| Advanced Optical Microscopy: Unveiling Functional Insights Regarding a Novel PPP2R1A Variant and Its Unreported Phenotype. | Int J Mol Sci | 2023 | 37762002 | PubTator, text mining | PubMed |
| Novel Variants of PPP2R1A in Catalytic Subunit Binding Domain and Genotype-Phenotype Analysis in Neurodevelopmentally Delayed Patients. | Genes (Basel) | 2023 | 37761890 | Swiss-Prot, curated | PubMed |
| Circulating Tumor Cells as a Promising Tool for Early Detection of Hepatocellular Carcinoma. | Cells | 2023 | 37759483 | PubTator, text mining | PubMed |
| Assembloid CRISPR screens reveal impact of disease genes in human neurodevelopment. | Nature | 2023 | 37758944 | PubTator, text mining | PubMed |
| Genetic analysis of fundic gland‑type gastric adenocarcinoma. | Mol Clin Oncol | 2023 | 37745263 | PubTator, text mining | PubMed |
| Protection of eIF2B from inhibitory phosphorylated eIF2: A viral strategy to maintain mRNA translation during the PKR-triggered integrated stress response. | J Biol Chem | 2023 | 37742919 | PubTator, text mining | PubMed |
| Sequencing-based transcriptome analysis reveals diversification of immune response- and angiogenesis-related expression patterns of early-stage cervical carcinoma as compared with high-grade CIN. | Front Immunol | 2023 | 37731500 | PubTator, text mining | PubMed |
| Challenges in diagnosis and treatment: a case report on a mixed malignant Müllerian tumor. | J Surg Case Rep | 2023 | 37724065 | PubTator, text mining | PubMed |
| Phosphorylation of axin within biomolecular condensates counteracts its tankyrase-mediated degradation. | J Cell Sci | 2023 | 37721093 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5518/papers?page=6